| Host: | HEK293 cells |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Unconjugated |
| Formulation: | Lyophilised from a 0.22 Mu m filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation. |
| Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Determination Method: | < 1 EU/Mu g of the protein by LAL method. |
| Immunogen Region: | Val16-Glu1213 |
| Immunogen: | Recombinant SARS-CoV-2 Spike S1+S2 ECD (S-ECD) (B.1.1.529/Omicron) Trimer Protein is produced by Expi293 expression system. The target protein is expressed with sequence ( Val16-Glu1213) of SARS-COV-2 Spike S (B.1.1.529/Omicron) (Accession #QHO60594. |
| Immunogen Sequence: | Val16-Glu1213 (A67V, HV69-70del, T95I, G1 42D, VYY143-145del, N211del, L212I, ins2 14EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477 N, T478K, E484A, Q49 3R, G496S, Q498R, N5 01Y, Y505H, T547K, D 614G, H655Y, N679K, P681H, N764K, D796Y, N8 |
| Background | The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Information sourced from Uniprot.org
